These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 20953255)
21. Re: Bioethics, the Surviving Sepsis Campaign, and the industry. Ricevuti G; Gasparetto C Wien Klin Wochenschr; 2006 Feb; 118(1-2):64-5. PubMed ID: 16612880 [No Abstract] [Full Text] [Related]
22. Re: Bioethics, the Surviving Sepsis Campaign, and the industry. Mackenzie AF Wien Klin Wochenschr; 2006 Feb; 118(1-2):64. PubMed ID: 16612879 [No Abstract] [Full Text] [Related]
23. Re: Bioethics, the Surviving Sepsis Campaign, and the industry. Malliani A Wien Klin Wochenschr; 2006 Feb; 118(1-2):63-4. PubMed ID: 16612878 [No Abstract] [Full Text] [Related]
24. Publication ethics and scientific misconduct: the role of authors. Luther F J Orthod; 2008 Mar; 35(1):1-4. PubMed ID: 18287388 [No Abstract] [Full Text] [Related]
25. Pharmaceutical influence on clinical science and practice: a double-edged sword. Sartor RB Gastroenterology; 2004 Sep; 127(3):703-4. PubMed ID: 15362023 [No Abstract] [Full Text] [Related]
26. Correspondence (letter to the editor): National foundation. Freund M Dtsch Arztebl Int; 2010 Sep; 107(38):671; author reply 673-4. PubMed ID: 20953259 [No Abstract] [Full Text] [Related]
28. The sins of ghostwriting. Somberg JC Am J Ther; 2008; 15(4):297-8. PubMed ID: 18645328 [No Abstract] [Full Text] [Related]
29. Publish or be damned. Vines G New Sci; 1997 Sep; 155(2099):53. PubMed ID: 16127834 [No Abstract] [Full Text] [Related]
30. Publication ethics: what next? (Letter to the editor). Wiwanitkit V Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):234. PubMed ID: 26076797 [No Abstract] [Full Text] [Related]
33. Publication ethics and the ghost management of medical publication. Sismondo S; Doucet M Bioethics; 2010 Jul; 24(6):273-83. PubMed ID: 19222451 [TBL] [Abstract][Full Text] [Related]
34. "Good Publication Practice for Pharmaceutical Companies": where are we now? Wager E MedGenMed; 2005 Apr; 7(2):6. PubMed ID: 16369385 [TBL] [Abstract][Full Text] [Related]
35. Bias in the design, interpretation, and publication of industry-sponsored clinical research. Hammerschmidt D Minn Med; 2008 Jun; 91(6):46-7. PubMed ID: 18616022 [No Abstract] [Full Text] [Related]
36. Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? Yes. Goldacre B BMJ; 2009 Nov; 339():b4949. PubMed ID: 19946143 [No Abstract] [Full Text] [Related]
37. Falling out with pharma. Whitehead S Lancet; 2013 Mar; 381(9872):1096-7. PubMed ID: 23540851 [No Abstract] [Full Text] [Related]
38. Research ethics and scientific misconduct in biomedical research. Kansu E; Ruacan S Acta Neurochir Suppl; 2002; 83():11-5. PubMed ID: 12442615 [TBL] [Abstract][Full Text] [Related]
39. The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials. Schott G; Pachl H; Limbach U; Gundert-Remy U; Ludwig WD; Lieb K Dtsch Arztebl Int; 2010 Apr; 107(16):279-85. PubMed ID: 20467553 [TBL] [Abstract][Full Text] [Related]